Q-C Technologies Inc

Q‑C insider buying signals strong confidence in its medical‑device strategy and potential biopharma partnerships, highlighting regulatory, reimbursement, and growth opportunities.

Voss Chelsea Sierra’s board‑level RSU grant signals a strategic shift for Q‑C Technologies, aligning executive incentives with a turnaround amid a steep share‑price decline.